Medication info
Memotin 5 mg Tablets (Memantine Hydrochloride)

Memotin 5 mg Tablets (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›5mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Approval status
Active

MFDS item code 202503175 · Approved 2025.12.05

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This medicine is administered orally once daily at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1~7): Administer 5mg once daily for 7 days. Week 2 (Days 8~14): Administer 10mg once daily for 7 days. Week 3 (Days 15~21): Administer 15mg once daily for 7 days. From Week 4 onward, administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Elderly patients Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg daily. 3. Patients with renal impairment No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg daily according to the standard dose escalation schedule no earlier than 7 days after administration. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease. It helps alleviate cognitive decline in patients and improve the quality of daily life.

How to take

Adult dose

This medicine is administered orally once daily at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1~7): Administer 5mg once daily for 7 days. Week 2 (Days 8~14): Administer 10mg once daily for 7 days. Week 3 (Days 15~21): Administer 15mg once daily for 7 days. From Week 4 onward, administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg daily. 2. Elderly patients Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg daily. 3. Patients with renal impairment No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated, the dose may be increased to 20mg daily according to the standard dose escalation schedule no earlier than 7 days after administration. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This medication should not be used in patients with allergies to its components. It should also be avoided in patients with very poor liver function and severely impaired kidney function. Caution is necessary when used in patients with a history of seizures or epilepsy, or those predisposed to seizures. It is advisable not to take it together with specific medications such as amantadine, ketamine, or dextromethorphan, as it may increase central nervous system side effects. Patients with factors or conditions that may alter urine acidity should be carefully monitored. Caution is required when used in patients with uncontrolled heart disease or hypertension. During treatment with this medication, symptoms such as dizziness, headache, constipation, drowsiness, and hypertension may occur; patients should consult a doctor if any unusual symptoms arise. It is important to inform the doctor of any interactions with other medications, especially antipsychotics, muscle relaxants, or anticoagulants. Pregnant women or women who may become pregnant should carefully consider the risks and benefits of using this medication, and breastfeeding should be discontinued if it is used. It is recommended not to use this medication in children or adolescents under 18 years of age as safety and efficacy have not been established. In case of overdose, symptoms such as confusion, drowsiness, dizziness, and vomiting may occur; therefore, it is essential to follow the prescribed dosage and report any unusual symptoms to medical personnel immediately. This medication may affect the patient's reaction time, so caution is needed when driving or operating machinery. Keep the medication out of reach of children and do not transfer it to another container.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucinations
  • psychiatric reactions
Show 19 more
  • balance disorder
  • gait abnormalities
  • seizures
  • heart failure
  • venous thrombosis/thromboembolism
  • respiratory distress
  • vomiting
  • pancreatitis
  • elevated liver function test values
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • agitation
  • aggressiveness
  • lethargy
  • unconsciousness
  • double vision

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 and 30 degrees Celsius. This will help retain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.